Evercore ISI Group Maintains Outperform on 89bio, Raises Price Target to $37
Portfolio Pulse from Benzinga Newsdesk
Evercore ISI Group analyst Liisa Bayko has maintained an Outperform rating on 89bio (NASDAQ:ETNB) and increased the price target from $29 to $37.
March 06, 2024 | 7:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Evercore ISI Group analyst Liisa Bayko reaffirmed an Outperform rating on 89bio and raised the price target from $29 to $37.
The increase in price target by a reputable analyst such as Liisa Bayko from Evercore ISI Group suggests a strong confidence in 89bio's future performance. This endorsement is likely to positively influence investor sentiment and could lead to a short-term increase in the stock price of ETNB.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100